Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fibrinogen antagonists from Yamanouchi

Aug. 20, 1997

Stanford announces three studies on leg ischemia treatments

Aug. 20, 1997

Glaxo Wellcome discloses a new series of thrombin inhibitors

Aug. 18, 1997

Arginine mimetics from Boehringer Mannheim

Aug. 13, 1997

Normiflo launched in U.S.

Aug. 12, 1997

Dietary changes may pose threat to patients on oral anticoagulants

Aug. 8, 1997

Texas Biotechnology and SmithKline Beecham form marketing alliance for Novastan

Aug. 7, 1997

Berlex reports novel anticoagulants

Aug. 6, 1997

Barr Laboratories halts shipment of warfarin educational materials

Aug. 6, 1997

Generic warfarin shipments begin

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.